9-137192572-TTCCTCCTCCTCCTCCTCC-TTCCTCCTCCTCC

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS1

The NM_001128228.3(TPRN):​c.1839_1844delGGAGGA​(p.Glu614_Glu615del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000663 in 1,608,372 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E613E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 1 hom. )

Consequence

TPRN
NM_001128228.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.06

Publications

3 publications found
Variant links:
Genes affected
TPRN (HGNC:26894): (taperin) This locus encodes a sensory epithelial protein. It was defined by linkage analysis in three Pakistani families to lie between D9S1818 (centromeric) and D9SH6 (telomeric). Mutations at this locus have been associated with autosomal recessive deafness. [provided by RefSeq, Oct 2010]
TPRN Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 79
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001128228.3
BP6
Variant 9-137192572-TTCCTCC-T is Benign according to our data. Variant chr9-137192572-TTCCTCC-T is described in ClinVar as Benign. ClinVar VariationId is 179337.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00165 (250/151268) while in subpopulation EAS AF = 0.0101 (51/5068). AF 95% confidence interval is 0.00786. There are 1 homozygotes in GnomAd4. There are 132 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TPRNNM_001128228.3 linkc.1839_1844delGGAGGA p.Glu614_Glu615del disruptive_inframe_deletion Exon 2 of 4 ENST00000409012.6 NP_001121700.2 Q4KMQ1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TPRNENST00000409012.6 linkc.1839_1844delGGAGGA p.Glu614_Glu615del disruptive_inframe_deletion Exon 2 of 4 1 NM_001128228.3 ENSP00000387100.4 Q4KMQ1-1
TPRNENST00000477345.1 linkn.2560_2565delGGAGGA non_coding_transcript_exon_variant Exon 1 of 3 1
TPRNENST00000333046.8 linkc.1233_1238delGGAGGA p.Glu412_Glu413del disruptive_inframe_deletion Exon 2 of 3 2 ENSP00000327617.4 H3BLU1
TPRNENST00000541945.1 linkn.*74_*79delGGAGGA downstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.00165
AC:
250
AN:
151156
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00309
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00224
Gnomad ASJ
AF:
0.000868
Gnomad EAS
AF:
0.0100
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.000191
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000339
Gnomad OTH
AF:
0.00241
GnomAD2 exomes
AF:
0.00188
AC:
395
AN:
209928
AF XY:
0.00165
show subpopulations
Gnomad AFR exome
AF:
0.00349
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.000554
Gnomad EAS exome
AF:
0.0172
Gnomad FIN exome
AF:
0.0000545
Gnomad NFE exome
AF:
0.000217
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.000561
AC:
817
AN:
1457104
Hom.:
1
AF XY:
0.000534
AC XY:
387
AN XY:
724688
show subpopulations
African (AFR)
AF:
0.00342
AC:
114
AN:
33352
American (AMR)
AF:
0.00117
AC:
52
AN:
44342
Ashkenazi Jewish (ASJ)
AF:
0.000422
AC:
11
AN:
26056
East Asian (EAS)
AF:
0.00812
AC:
321
AN:
39550
South Asian (SAS)
AF:
0.000338
AC:
29
AN:
85878
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52510
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5754
European-Non Finnish (NFE)
AF:
0.000210
AC:
233
AN:
1109458
Other (OTH)
AF:
0.000880
AC:
53
AN:
60204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00165
AC:
250
AN:
151268
Hom.:
1
Cov.:
33
AF XY:
0.00179
AC XY:
132
AN XY:
73908
show subpopulations
African (AFR)
AF:
0.00310
AC:
128
AN:
41254
American (AMR)
AF:
0.00217
AC:
33
AN:
15190
Ashkenazi Jewish (ASJ)
AF:
0.000868
AC:
3
AN:
3458
East Asian (EAS)
AF:
0.0101
AC:
51
AN:
5068
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4788
European-Finnish (FIN)
AF:
0.000191
AC:
2
AN:
10456
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000339
AC:
23
AN:
67754
Other (OTH)
AF:
0.00239
AC:
5
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000110
Hom.:
0
Bravo
AF:
0.00219

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 05, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glu620_Glu621del in Exon 2 of TPRN: This variant is not expected to have clinica l significance because it has been identified in 1.5% (114/7666) of European Ame rican chromosomes and 1.2% (46/3904) of African American chromosomes by the NHLB I Exome sequencing project (http://evs.gs.washington.edu/EVS/; dbSNP rs77086130) . -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.1
Mutation Taster
=170/30
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376810326; hg19: chr9-140087024; API